Antiprotozoals for trichomoniasis

References

Citations

  1. U.S. Department of Health and Human Services (2006). Sexually Transmitted Diseases Treatment Guidelines, 2006 (CDC Publication Vol. 55, No. RR-11), pp. 52–54. Atlanta: U.S. Department of Health and Human Services. Also available online: http://www.cdc.gov/STD/treatment/2006/rr5511.pdf.

  2. Sobel JD, et al. (2001). Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clinical Infectious Diseases, 33: 1341–1346.

  3. Feola DJ, et al. (2002). Metronidazole-induced pancreatitis in a patient with recurrent vaginal trichomoniasis. Pharmacotherapy, 22(11): 1508–1510.

  4. Klebanoff MA, et al. (2001). Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. New England Journal of Medicine, 345(7): 487–493.



Author: Amy Fackler, MA
Debby Golonka, MPH
Last Updated: August 10, 2006
Medical Review: Renée M. Crichlow, MD - Family Medicine
Kathleen Romito, MD - Family Medicine
Jeanne Marrazzo, MD, MPH - Infectious Disease

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References